| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6185550 | Gynecologic Oncology | 2013 | 7 Pages |
Abstract
1-TFF3 seems to be a novel pathway in the pathogenesis of type I endometrial carcinomas. 2-The strong association of TFF3 and ER in the estrogen-dependent endometrioid carcinoma could explain the reason for its frequent expression by this tumor type. 3-TFF3+ seems to forecast a good prognosis in type I endometrial carcinomas. Based on our data, TFF3 expression in endometrial cancer deserves further investigation.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Paulette Mhawech-Fauceglia, Dan Wang, Damanzoopinder Samrao, Song Liu, Nefertiti C. duPont, Tanja Pejovic,